Products 1427189-02-3

CAS 1427189-02-3 appears in our catalog under these names: 16,17-Didehydroganoderic acid D, ≥98%, ≥98%, 3,11,15,23-Tetraoxo-27ξ-lanosta-8,16-dien-26-oic acid. Offered by: Chemat, MedChemExpress. Available pack sizes: 20mg, 10mg, 25mg, 5mg.

16,17-Didehydroganoderic acid D, ≥98%, ≥98%
Chemat
  • size: 20mg
  • Variants: 1
from 5973.20
View product
3,11,15,23-Tetraoxo-27ξ-lanosta-8,16-dien-26-oic acid
MedChemExpress
  • size: 10mg, 25mg, 5mg
  • Variants: 3
View product
Structural formula: {0} (CAS {1})

3,11,15,23-tetraoxo-27xi-lanosta-8,16-dien-26-oic acid is a triterpenoid.

Source: ChEBI

Identity
Molecular formulaC30H40O7
Molecular weight512.6 g/mol
IUPAC name(6R)-6-[(5R,7S,10S,13R,14R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12-hexahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
InChIKeyYBFMHFRKIFVPJA-LRGPFVJBSA-N
SMILESC[C@H](CC(=O)CC(C)C(=O)O)C1=CC(=O)[C@@]2([C@@]1(CC(=O)C3=C2[C@H](C[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)O)C)C

Computed by PubChem (NCBI)

Synonyms: 16,17-Didehydroganoderic acid D, 3,11,15,23-Tetraoxo-27xi-lanosta-8,16-dien-26-oic acid, 3,11,15,23-Tetraoxo-27|I-lanosta-8,16-dien-26-oic acid, orb1984773, 3,11,15,23-Tetraoxo-27??-lanosta-8,16-dien-26-oic acid, 3,11,15,23-tetraoxo-27xi-lanosta-8,16-dien- 26-oic acid, 7beta-hydroxy-3,11,15,23-tetraoxo-27xi-lanosta-8,16-dien-26-oic acid
Isomers (same molecular formula)
(2R,6R)-2-methyl-4-oxo-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid C30H40O7
6-(3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid C30H40O7
[(1R,2R,5S,6R,10R,11S,12R,15R,16R,18S,19R)-18-acetyloxy-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadec-8-en-16-yl] acetate C30H40O7
(E,4S,6R)-4-hydroxy-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid C30H40O7
(E)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid C30H40O7
[(1S,2R,7S,9R,11R,12S,13S,15R,16R)-15-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-13-yl] acetate C30H40O7
(Z,2R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid C30H40O7
(E)-6-[(2R,3S,7R,9S,11R,15R,17R)-9,17-dihydroxy-2,6,6,11,15-pentamethyl-5,12-dioxo-14-pentacyclo[8.7.0.02,7.03,17.011,15]heptadec-1(10)-enyl]-2-methyl-4-oxohept-5-enoic acid C30H40O7